{"id":"https://openalex.org/W2761275930","doi":"https://doi.org/10.1111/bcp.13435","title":"Phenytoin: its potential as neuroprotective and retinoprotective drug","display_name":"Phenytoin: its potential as neuroprotective and retinoprotective drug","publication_year":2017,"publication_date":"2017-10-12","ids":{"openalex":"https://openalex.org/W2761275930","doi":"https://doi.org/10.1111/bcp.13435","mag":"2761275930","pmid":"https://pubmed.ncbi.nlm.nih.gov/29027243","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5736838"},"language":"en","primary_location":{"id":"doi:10.1111/bcp.13435","doi":"https://doi.org/10.1111/bcp.13435","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.13435","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC5736838","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074600789","display_name":"Flavia Chiosi","orcid":"https://orcid.org/0000-0002-1728-6098","observed_orcids":["https://orcid.org/0000-0002-1728-6098"]},"institutions":[{"id":"https://openalex.org/I129627893","display_name":"University of Molise","ror":"https://ror.org/04z08z627","country_code":"IT","type":"education","lineage":["https://openalex.org/I129627893"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Flavia Chiosi","raw_affiliation_strings":["Eye Clinic, Department of Medicine and Health Sciences University of Molise Campobasso Italy"],"raw_orcid":"https://orcid.org/0000-0002-1728-6098","affiliations":[{"raw_affiliation_string":"Eye Clinic, Department of Medicine and Health Sciences University of Molise Campobasso Italy","institution_ids":["https://openalex.org/I129627893"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023684451","display_name":"Jan Keppel Hesselink","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I155976169","display_name":"Witten/Herdecke University","ror":"https://ror.org/00yq55g44","country_code":"DE","type":"education","lineage":["https://openalex.org/I155976169"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jan Keppel Hesselink","raw_affiliation_strings":["Department of Health University of Witten/Herdecke Witten Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health University of Witten/Herdecke Witten Germany","institution_ids":["https://openalex.org/I155976169"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101577407","display_name":"Michele Rinaldi","orcid":"https://orcid.org/0000-0003-1823-1686","observed_orcids":["https://orcid.org/0000-0003-1823-1686"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Michele Rinaldi","raw_affiliation_strings":["Department of Ophthalmology Seconda Universit\u00e0 degli Studi di Napoli Naples Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ophthalmology Seconda Universit\u00e0 degli Studi di Napoli Naples Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026273790","display_name":"Silvio Di Staso","orcid":"https://orcid.org/0000-0001-7477-4939","observed_orcids":["https://orcid.org/0000-0001-7477-4939"]},"institutions":[{"id":"https://openalex.org/I26415053","display_name":"University of L'Aquila","ror":"https://ror.org/01j9p1r26","country_code":"IT","type":"education","lineage":["https://openalex.org/I26415053"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvio Di Staso","raw_affiliation_strings":["Department of Surgical Science, Ophthalmic Clinic University of L'Aquila L'Aquila Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Science, Ophthalmic Clinic University of L'Aquila L'Aquila Italy","institution_ids":["https://openalex.org/I26415053"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033552009","display_name":"Silvia Bartollino","orcid":"https://orcid.org/0000-0001-7105-6392","observed_orcids":["https://orcid.org/0000-0001-7105-6392"]},"institutions":[{"id":"https://openalex.org/I129627893","display_name":"University of Molise","ror":"https://ror.org/04z08z627","country_code":"IT","type":"education","lineage":["https://openalex.org/I129627893"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Silvia Bartollino","raw_affiliation_strings":["Eye Clinic, Department of Medicine and Health Sciences University of Molise Campobasso Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eye Clinic, Department of Medicine and Health Sciences University of Molise Campobasso Italy","institution_ids":["https://openalex.org/I129627893"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023102332","display_name":"Ciro Costagliola","orcid":"https://orcid.org/0000-0001-8477-6188","observed_orcids":["https://orcid.org/0000-0001-8477-6188"]},"institutions":[{"id":"https://openalex.org/I129627893","display_name":"University of Molise","ror":"https://ror.org/04z08z627","country_code":"IT","type":"education","lineage":["https://openalex.org/I129627893"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Ciro Costagliola","raw_affiliation_strings":["Eye Clinic, Department of Medicine and Health Sciences University of Molise Campobasso Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eye Clinic, Department of Medicine and Health Sciences University of Molise Campobasso Italy","institution_ids":["https://openalex.org/I129627893"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5074600789"],"corresponding_institution_ids":["https://openalex.org/I129627893"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.6563,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.66843831,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"84","issue":"1","first_page":"195","last_page":"196"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.9018999934196472,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.9018999934196472,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.05620000138878822,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10706","display_name":"Traumatic Brain Injury and Neurovascular Disturbances","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9940000176429749},{"id":"https://openalex.org/keywords/retinoprotection","display_name":"retinoprotection","score":0.9980000257492065},{"id":"https://openalex.org/keywords/optic-neuritis","display_name":"optic neuritis","score":0.9110000133514404},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9879999756813049},{"id":"https://openalex.org/keywords/retinal-nerve-fiber-layer-thickness","display_name":"retinal nerve fiber layer thickness","score":0.8629999756813049},{"id":"https://openalex.org/keywords/sodium-channel-inhibition","display_name":"sodium channel inhibition","score":0.5440000295639038},{"id":"https://openalex.org/keywords/axonal-loss","display_name":"axonal loss","score":0.6110000014305115},{"id":"https://openalex.org/keywords/optic-neuropathy","display_name":"optic neuropathy","score":0.47699999809265137},{"id":"https://openalex.org/keywords/glaucoma","display_name":"glaucoma","score":0.6919999718666077},{"id":"https://openalex.org/keywords/hypoxia","display_name":"hypoxia","score":0.40700000524520874},{"id":"https://openalex.org/keywords/anoxia","display_name":"anoxia","score":0.6240000128746033},{"id":"https://openalex.org/keywords/surrogate-endpoints","display_name":"surrogate endpoints","score":0.5239999890327454},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.628000020980835},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.7509999871253967},{"id":"https://openalex.org/keywords/optical-coherence-tomography","display_name":"optical coherence tomography","score":0.597000002861023},{"id":"https://openalex.org/keywords/axon-degeneration","display_name":"axonal degeneration","score":0.4740000069141388},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.9256986379623413},{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.8699281215667725},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.7136863470077515},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6760089993476868},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6581997871398926},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5489127039909363},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5353257060050964},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4153992533683777},{"id":"https://openalex.org/C50952357","wikidata":"https://www.wikidata.org/wiki/Q424960","display_name":"Sodium channel","level":3,"score":0.41419151425361633},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.32079365849494934},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.30904918909072876},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19458460807800293},{"id":"https://openalex.org/C537181965","wikidata":"https://www.wikidata.org/wiki/Q658","display_name":"Sodium","level":2,"score":0.10986170172691345},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.10932189226150513},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009902","descriptor_name":"Optic Neuritis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012160","descriptor_name":"Retina","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1111/bcp.13435","doi":"https://doi.org/10.1111/bcp.13435","is_oa":false,"landing_page_url":"https://doi.org/10.1111/bcp.13435","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5282116","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5736838","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:29027243","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29027243","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Letter"},{"id":"pmh:oai:pubmedcentral.nih.gov:5736838","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5736838/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmh:oai:iris.unicampania.it:11591/383040","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11591/383040","pdf_url":null,"source":{"id":"https://openalex.org/S7407055255","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi della Campania \"Luigi Vanvitelli\"","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.unimol.it:11695/69063","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11695/69063","pdf_url":null,"source":{"id":"https://openalex.org/S7407055127","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi del Molise","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:ricerca.univaq.it:11697/118172","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11697/118172","pdf_url":null,"source":{"id":"https://openalex.org/S7407055225","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi dell Aquila","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5282116","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC5736838","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W2068648104","https://openalex.org/W2077903158","https://openalex.org/W2105160857","https://openalex.org/W2144665769","https://openalex.org/W2158386281","https://openalex.org/W2194756172","https://openalex.org/W2270933859"],"related_works":["https://openalex.org/W2897049643","https://openalex.org/W2463978450","https://openalex.org/W2921144541","https://openalex.org/W2736398003","https://openalex.org/W2612207898","https://openalex.org/W2004734475","https://openalex.org/W2328511341","https://openalex.org/W2486188651","https://openalex.org/W2024841411","https://openalex.org/W2032370326"],"abstract_inverted_index":{"The":[0,173,283,325,349],"concept":[1],"of":[2,53,74,95,104,134,176,194,196,204,255,285,322,328,357,379,409,444,467,493,500,524,531,541,568,588],"neuroprotection":[3,70,231,555],"can":[4,155,209,273,302],"be":[5,84,210,235,274,303,370,458,512,576],"found":[6,366],"in":[7,71,131,142,150,260,266,288,299,332,340,376,473,483,497,514,521,526,529,556,560,610,618],"the":[8,11,51,54,61,81,93,132,164,181,192,242,252,289,315,355,361,377,397,403,407,442,445,465,479,532,550,561,566,569,589,620,626],"literature":[9],"from":[10,625],"1940s":[12],"onwards.":[13],"It":[14,146,503],"was":[15,29,66,78,170,330,487],"initially":[16],"linked":[17],"to":[18,23,43,159,168,213,270,369,452,564,578,615,629,637],"protection":[19],"against":[20],"convulsions":[21],"due":[22,158],"anticonvulsants,":[24],"barbiturates":[25],"and":[26,28,37,47,57,59,107,136,163,184,187,263,279,306,382,402,416,463,475,520,538,604],"phenytoin,":[27],"therefore":[30],"based":[31,200],"on":[32,45,85,118,201,249,257,396],"a":[33,123,188,219,319,333,373,393,413,470],"clinical":[34,62,96,119,258,335],"endpoint.":[35],"Neuroprotection":[36],"retinoprotection":[38,250],"as":[39,88,128,226,237,239,360,428,430,441,469,597],"definitions":[40],"were":[41,178,417],"related":[42],"effects":[44,175],"physiological":[46],"functional":[48],"parameters,":[49,76],"at":[50,60,139,180],"level":[52],"cells,":[55,399],"tissues":[56],"organs,":[58],"level.":[63],"As":[64],"there":[65],"consistent":[67],"evidence":[68],"for":[69,191,232,460,554,623],"both":[72],"groups":[73],"outcome":[75,363],"it":[77],"recommended":[79],"that":[80,103,153,390,506,593],"focus":[82,116],"should":[83,234,422,546],"structural":[86,105,438],"endpoints":[87,97,259],"primary":[89,362],"surrogate":[90],"endpoints.":[91,120],"Moreover,":[92],"sensitivity":[94],"is":[98,122,137,223,504],"generally":[99],"much":[100],"lower":[101],"than":[102,581],"endpoints,":[106,439],"we":[108,115],"might":[109,457],"lose":[110],"valuable":[111],"retinoprotective":[112,326,471],"drugs":[113,595],"if":[114],"only":[117],"Phenytoin":[121,208],"selective":[124],"sodium-channel":[125,508],"inhibitor,":[126],"used":[127,577],"an":[129,488,498],"anticonvulsant":[130],"treatment":[133],"epilepsy":[135],"neuroprotective":[138,513,594],"therapeutic":[140,215,552],"concentrations":[141,217],"experimental":[143,229],"models":[144],"1.":[145],"has":[147,392],"been":[148],"documented":[149],"animal":[151],"experiments":[152],"phenytoin":[154,177,197,256,329,367,391,468,486,598],"reduce":[156],"mortality":[157],"anoxia":[160],"or":[161],"hypoxia,":[162],"major":[165,414],"endpoint":[166],"pointing":[167],"\u2018protection\u2019":[169],"\u2018survival":[171],"time\u2019.":[172],"protective":[174,253,394],"defined":[179],"cellular,":[182],"tissue":[183],"organ":[185],"levels,":[186],"unifying":[189],"hypothesis":[190],"mechanism":[193],"action":[195],"became":[198],"established,":[199],"its":[202],"prevention":[203],"intracellular":[205],"sodium":[206,495],"accumulation.":[207],"loaded":[211],"rapidly,":[212],"achieve":[214],"serum":[216],"within":[218],"few":[220],"days;":[221],"this":[222,410,484,573,611],"important":[224],"because,":[225],"suggested":[227],"by":[228,296,345],"studies,":[230],"relapses":[233],"started":[236],"early":[238],"possible":[240],"during":[241],"acute":[243,386,517,535],"inflammatory":[244,501],"injury":[245],"phase":[246,336],"2.":[247],"Studies":[248],"evaluated":[251],"effect":[254,327,395],"optic":[261,267,300,346,387,404,476,518,536],"neuritis":[262,268,301,347,519,537],"glaucoma.":[264],"Retinoprotection":[265],"secondary":[269],"multiple":[271,341,527],"sclerosis":[272,342],"tested":[275],"using":[276,308,354],"clinical,":[277],"electrophysiological":[278],"imaging":[280],"techniques":[281],"3.":[282],"thickness":[284,317,381,443],"unmyelinated":[286],"axons,":[287],"retinal":[290,435],"nerve":[291],"fibre":[292],"layer":[293],"(RNFL)":[294],"affected":[295,344],"retrograde":[297],"degeneration":[298],"measured":[304],"sensitively":[305],"non-invasively":[307],"optical":[309],"coherence":[310],"tomography":[311],"(OCT)":[312],"4.":[313],"Therefore,":[314],"RNFL":[316,358,380],"provides":[318],"plausible":[320],"biomarker":[321],"axonal":[323],"loss.":[324],"supported":[331],"recent":[334],"II":[337],"proof-of-concept":[338],"study":[339,411],"patients":[343,515],"5.":[348],"authors":[350],"considered":[351,459],"OCT":[352,426,433,449],"evaluation,":[353],"measurement":[356],"thickness,":[359],"measure.":[364],"They":[365],"use":[368,466],"associated":[371],"with":[372,448,516],"significant":[374],"reduction":[375],"loss":[378],"macular":[383],"volume":[384],"after":[385],"neuritis,":[388],"suggesting":[389],"ganglion":[398,454],"their":[400],"axons":[401],"nerve.":[405],"Although":[406],"results":[408],"represented":[412],"advancement,":[415],"undeniably":[418],"encouraging,":[419],"future":[420],"studies":[421,545],"include":[423],"more":[424,431,548,580],"frequent":[425],"sampling,":[427],"well":[429],"detailed":[432],"segmentation-derived":[434],"measures.":[436],"Basically,":[437],"such":[440,596],"RNFL,":[446],"along":[447],"segmentation":[450],"methods":[451],"estimate":[453],"neurone":[455],"integrity,":[456],"widely":[461],"testing":[462],"exploring":[464],"drug":[472],"glaucoma":[474],"neuritis.":[477],"At":[478],"average":[480],"concentration":[481],"achieved":[482],"trial,":[485],"almost":[489],"pure":[490],"activity-dependent":[491],"inhibitor":[492],"voltage-gated":[494],"channels":[496],"episode":[499],"demyelination.":[502],"conceivable":[505],"other":[507,522,539],"inhibitors":[509],"could":[510,575,599],"also":[511],"types":[523,540],"relapse":[525,542],"sclerosis,":[528],"view":[530],"similarities":[533],"between":[534],"6.":[543],"Future":[544],"establish":[547],"precisely":[549],"optimal":[551],"window":[553],"relapses.":[557],"What":[558],"happens":[559],"eye":[562,583],"seems":[563],"mirror":[565],"rest":[567],"brain,":[570],"so":[571],"potentially":[572],"approach":[574],"treat":[579],"just":[582],"attacks,":[584],"but":[585],"any":[586],"flare-up":[587],"disease.":[590],"We":[591],"believe":[592],"complement":[600],"existing":[601],"immunomodulating":[602],"therapies":[603],"potential":[605],"remyelination":[606],"approaches.":[607],"Key":[608],"ligands":[609],"article":[612],"are":[613,633],"hyperlinked":[614],"corresponding":[616],"entries":[617],"http://www.guidetopharmacology.org,":[619],"common":[621],"portal":[622],"data":[624],"IUPHAR/BPS":[627],"Guide":[628],"PHARMACOLOGY":[630],"7.":[631],"There":[632],"no":[634],"competing":[635],"interests":[636],"declare.":[638]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2017-10-20T00:00:00"}